The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis

Kyoji Urayama1, Célia Guilini, Nadia Messaddeq

  • 1UMR 7175/CNRS/Universite Strasbourg I, Ecole Supérieure de Biotechnologie de Strasbourg, Bld. Sébastien Brandt BP. 10413, F-67412 Illkirch, France.

Insights

Prokineticin receptor-1 (PKR1) signaling promotes heart repair after myocardial infarction by enhancing blood vessel formation and protecting heart cells. PKR1 gene transfer reduced mortality and improved heart function in a mouse model.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Regenerative Medicine

Background:

  • Prokineticins are angiogenic factors acting through G protein-coupled receptors.
  • Prokineticin receptor-1 (PKR1/GPR73) signaling's role in myocardial infarction is unknown.
  • Prokineticin-2 and PKR1 are expressed in adult mouse heart and cardiac cells.

Purpose of the Study:

  • Investigate the role of prokineticin-2 and PKR1 in cardiac cell function.
  • Determine if PKR1 gene transfer can protect the heart from myocardial infarction.

Main Methods:

  • In vitro studies using cultured cardiac endothelial cells and cardiomyocytes (H9c2 cells).
  • Overexpression and siRNA knockdown of PKR1.
  • Intramyocardial gene transfer of PKR1 in a mouse model of myocardial infarction.
  • Analysis of human end-stage failing heart samples.

Main Results:

  • Prokineticin-2 and PKR1 overexpression promoted vessel-like formation in endothelial cells and protected cardiomyocytes from oxidative stress via Akt activation.
  • PKR1 knockdown reversed these pro-survival and pro-angiogenic effects.
  • Intramyocardial PKR1 gene transfer reduced mortality, preserved left ventricular function, and promoted neovascularization post-myocardial infarction.
  • Reduced PKR1 and prokineticin-2 levels were observed in human failing hearts.

Conclusions:

  • PKR1 signaling is crucial for cardiomyocyte survival and angiogenesis in the context of myocardial infarction.
  • PKR1 gene transfer demonstrates therapeutic potential for limiting myocardial injury.
  • PKR1 represents a novel therapeutic target for ischemic heart disease.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...